Cargando…

Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations

Mutations constitutively activating FLT3 kinase are detected in ∼30% of acute myelogenous leukemia (AML) patients and affect downstream pathways such as extracellular signal–regulated kinase (ERK)1/2. We found that activation of FLT3 in human AML inhibits CCAAT/enhancer binding protein α (C/EBPα) fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radomska, Hanna S., Bassères, Daniela S., Zheng, Rui, Zhang, Pu, Dayaram, Tajhal, Yamamoto, Yukiya, Sternberg, David W., Lokker, Nathalie, Giese, Neill A., Bohlander, Stefan K., Schnittger, Susanne, Delmotte, Marie-Hélène, Davis, Roger J., Small, Donald, Hiddemann, Wolfgang, Gilliland, D. Gary, Tenen, Daniel G.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2006
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118199/ https://www.ncbi.nlm.nih.gov/pubmed/16446383 http://dx.doi.org/10.1084/jem.20052242

Ejemplares similares

Down regulation of PSA by C/EBPα is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell Line
por: Yin, Hong, et al.
Publicado: (2006)

Ubiquitination of HTLV-I Tax in response to DNA damage regulates nuclear complex formation and nuclear export
por: Gatza, Michael L, et al.
Publicado: (2007)

Activation of WIP1 Phosphatase by HTLV-1 Tax Mitigates the Cellular Response to DNA Damage
por: Dayaram, Tajhal, et al.
Publicado: (2013)

Targeting C/EBPα overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia
por: Wang, Hanlin, et al.
Publicado: (2023)

Styryl Quinazolinones as Potential Inducers of Myeloid Differentiation via Upregulation of C/EBPα
por: Sridhar, Radhakrishnan, et al.
Publicado: (2018)

Activating FLT3 Mutants Show Distinct Gain-of-Function Phenotypes In Vitro and a Characteristic Signaling Pathway Profile Associated with Prognosis in Acute Myeloid Leukemia
por: Janke, Hanna, et al.
Publicado: (2014)

Further Activation of FLT3 Mutants by FLT3 Ligand
por: Zheng, Rui, et al.
Publicado: (2011)

FLT3 in lineage specification and plasticity
por: Greenblatt, Sarah, et al.
Publicado: (2012)

Upregulation of Interleukin 6 and Granulocyte Colony-Stimulating Factor Receptors by Transcription Factor CCAAT Enhancer Binding Protein α (C/EBPα) Is Critical for Granulopoiesis
por: Zhang, Pu, et al.
Publicado: (1998)

Clonal heterogeneity of FLT3-ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemia
por: Schranz, Katrin, et al.
Publicado: (2018)

FLT3 and FLT3-ITD phosphorylate and inactivate the cyclin-dependent kinase inhibitor p27(Kip1) in acute myeloid leukemia
por: Peschel, Ines, et al.
Publicado: (2017)

DOCK2 Interacts with FLT3 and Modulates the Survival of FLT3-Expressing Leukemia Cells
por: Wu, Min, et al.
Publicado: (2016)

Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia
por: Reiter, K, et al.
Publicado: (2018)

Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3
por: Nagai, Kozo, et al.
Publicado: (2018)

Acetylation of C/EBPα inhibits its granulopoietic function
por: Bararia, Deepak, et al.
Publicado: (2016)

Capillary nano-immunoassay for Akt 1/2/3 and 4EBP1 phosphorylation in acute myeloid leukemia
por: Sabnis, Himalee, et al.
Publicado: (2014)

The new and recurrent FLT3 juxtamembrane deletion mutation shows a dominant negative effect on the wild-type FLT3 receptor
por: Sandhöfer, Nadine, et al.
Publicado: (2016)

The scaffolding protein EBP50 regulates microvillar assembly in a phosphorylation-dependent manner
por: Garbett, Damien, et al.
Publicado: (2010)

EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation
por: Yao, Wenfang, et al.
Publicado: (2012)

C/EBPβ-Thr217 Phosphorylation Stimulates Macrophage Inflammasome Activation and Liver Injury
por: Buck, Martina, et al.
Publicado: (2016)

Pim-1 Kinase Phosphorylates and Stabilizes 130 kDa FLT3 and Promotes Aberrant STAT5 Signaling in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication
por: Natarajan, Karthika, et al.
Publicado: (2013)

OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
por: Eisfelder, Bartholomew J., et al.
Publicado: (2021)

C/EBPβ-Thr217 Phosphorylation Signaling Contributes to the Development of Lung Injury and Fibrosis in Mice
por: Buck, Martina, et al.
Publicado: (2011)

p38β MAPK upregulates atrogin1/MAFbx by specific phosphorylation of C/EBPβ
por: Zhang, Guohua, et al.
Publicado: (2012)

Reciprocal Roles for CCAAT/Enhancer Binding Protein (C/EBP) and PU.1 Transcription Factors in Langerhans Cell Commitment
por: Iwama, Atsushi, et al.
Publicado: (2002)

FLT3 mutations in canine acute lymphocytic leukemia
por: Suter, Steven E, et al.
Publicado: (2011)

DOCK2: A novel FLT3/ITD leukemia drug target
por: Wu, Min, et al.
Publicado: (2017)

Disruption of the C/EBPα—miR-182 balance impairs granulocytic differentiation
por: Wurm, Alexander Arthur, et al.
Publicado: (2017)

Phosphorylation of Serine 248 of C/EBPα Is Dispensable for Myelopoiesis but Its Disruption Leads to a Low Penetrant Myeloid Disorder with Long Latency
por: Hasemann, Marie S., et al.
Publicado: (2012)

PlGF/FLT-1 deficiency leads to reduced STAT3-C/EBPβ signaling and aberrant polarization in decidual macrophages during early spontaneous abortion
por: Chang, Ruiqi, et al.
Publicado: (2023)

NUP98::Nsd1 and FLT3-ITD collaborate to generate acute myeloid leukemia
por: Matsukawa, Toshihiro, et al.
Publicado: (2023)

Ras-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferation
por: Lim, HooiCheng, et al.
Publicado: (2016)

Flt3 Ligand Regulates Dendritic Cell Development from Flt3(+) Lymphoid and Myeloid-committed Progenitors to Flt3(+) Dendritic Cells In Vivo
por: Karsunky, Holger, et al.
Publicado: (2003)

In Vivo Deficiency of Both C/EBPβ and C/EBPε Results in Highly Defective Myeloid Differentiation and Lack of Cytokine Response
por: Akagi, Tadayuki, et al.
Publicado: (2010)

WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma
por: Richter, Mark, et al.
Publicado: (2015)

Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
por: Maiti, Abhishek, et al.
Publicado: (2021)

“FLipping” the Story: FLT3-Mutated Acute Myeloid Leukemia and the Evolving Role of FLT3 Inhibitors
por: Knight, Tristan E., et al.
Publicado: (2022)

Myeloid transformation by MLL-ENL depends strictly on C/EBP
por: Wesolowski, Radoslaw, et al.
Publicado: (2020)

FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation
por: Zhu, Ruiqi, et al.
Publicado: (2021)

FLT3 inhibitors in acute myeloid leukemia
por: Wu, Mei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s3mvo3cbclbhra01tlonksf0o9